Ticker Scorecard - GNLX Basics Company: Genelux Corporation Common Stock IPO Date: January 26, 2023 Sector: Healthcare Industry: Biotech Market Cap: $166.13M Activated in VL: True Average Daily Range Avg Daily Range: $0.63 | 5.03% Avg Daily Range (30 D): $0.21 | 5.29% Avg Daily Range (90 D): $0.15 | 4.62% Institutional Daily Volume Avg Daily Volume: .12M Avg Daily Volume (30 D): .24M Avg Daily Volume (90 D): .17M Trade Size Avg Trade Size (Sh.): 97 Avg Trade Size (Sh.) (30 D): 140 Avg Trade Size (Sh.) (90 D): 162 Institutional Trades Total Inst.Trades: 26 Avg Inst. Trade: $3.65M Avg Inst. Trade (30 D): $1.1M Avg Inst. Trade (90 D): $1.1M Avg Inst. Trade Volume: .24M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.61M Avg Closing Trade (30 D): $3.23M Avg Closing Trade (90 D): $3.23M Avg Closing Volume: 413.66K     News Sep 3, 2024 @ 8:01 PM Genelux Corporation to Present at the H.C. Wainwri... Source: N/A Jul 30, 2024 @ 11:00 AM Genelux Corporation to Participate in Fireside Cha... Source: N/A May 31, 2024 @ 4:01 PM Unveiling 4 Analyst Insights On Genelux Source: Benzinga Insights May 24, 2024 @ 12:00 PM Genelux Corporation Announces Pricing of Approxima... Source: Genelux Corporation May 23, 2024 @ 8:01 PM Genelux Corporation Announces Proposed Public Offe... Source: Genelux Corporation Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.94 $-.19 $-.22 Diluted EPS $-.94 $-.19 $-.22 Revenue $ .01M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -27.66M $ -6.47M $ -6.58M Operating Income / Loss $ -28.95M $ -6.94M $ -6.89M Cost of Revenue $ $ $ Net Cash Flow $ -53.06M $ -1.76M $ 3.8M PE Ratio